Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Zhike Juhong granules for acute exacerbation of chronic obstructive pulmonary disease
CTR20260911Phase 2Active
- Sponsor
- Kangzhi Pharmaceutical
- Start
- May 2026
- Countries
- 1
01
Overview
A Phase 2 trial of zhike juhong granules in chronic obstructive pulmonary disease (COPD), sponsored by Kangzhi Pharmaceutical. Started May 2026; status: active.
02
Drugs
zhike juhong granules
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20260911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260911.